{"data":{"id":"us-va/18vac85-21-170","jurisdiction":"us-va","citation":"18VAC85-21-170","heading":"Medical records for opioid addiction treatment","body":"A. Records shall be timely, accurate, legible, complete, and readily accessible for review.\n\nB. The treatment agreement and informed consent shall be maintained in the medical record.\n\nC. Confidentiality requirements of 42 CFR Part 2 shall be followed.\n\nD. Compliance with 18VAC85-20-27, which prohibits willful or negligent breach of confidentiality or unauthorized disclosure of confidential Prescription Monitoring Program information, shall be maintained.","path":["Title 18. Professional And Occupational Licensing","Agency 85. Board of Medicine","Chapter 21. Regulations Governing Prescribing of Opioids and Buprenorphine","Part IV. Prescribing of Buprenorphine for \n Opioid Use Disorder"],"source_url":"https://law.lis.virginia.gov/admincode/title18/agency85/chapter21/section170/","current_through":"2026 Regular Session (effective July 1, 2026)","vintage":"","retrieved_at":"2026-09-14T04:52:45Z","sha256":"709b5d7aae822c4aabde8dd21d313cb4ca3bdb35b8d4c11d93aeba3a4c38931c","source_id":"us-va-vac","stale":false,"prev":"us-va/18vac85-21-160","next":"us-va/18vac85-40-10"},"notice":"GroundRules: Original legal text. Not legal advice."}